{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:42:25Z","timestamp":1770820945516,"version":"3.50.1"},"reference-count":43,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1638,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1365-2036.2011.04616.x","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T02:15:39Z","timestamp":1299636939000},"page":"1019-1027","source":"Crossref","is-referenced-by-count":15,"title":["Randomised clinical trial: twice daily esomeprazole 40\u2003mg vs. pantoprazole 40\u2003mg in Barrett\u2019s oesophagus for 1\u2003year"],"prefix":"10.1111","volume":"33","author":[{"given":"N.","family":"de Bortoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Martinucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Maltinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ciancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gambaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Lenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ricchiuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. G.","family":"Mumolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Blandizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0016-5085(87)90847-X","article-title":"Barrett\u2019s esophagus. A prevalent, occult complication of gastroesophageal reflux disease","volume":"92","author":"Winters","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1442-2050.2003.00284.x","article-title":"Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux","volume":"16","author":"Csendes","year":"2003","journal-title":"Dis Esophagus"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0016-5085(93)90420-H","article-title":"Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction","volume":"104","author":"Pera","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0016-5085(95)90642-8","article-title":"Adenocarcinoma of the esophagogastric junction and Barrett\u2019s esophagus","volume":"109","author":"Cameron","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1053\/gast.2002.33427","article-title":"Barrett\u2019s esophagus","volume":"122","author":"Falk","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0016-5085(84)90090-8","article-title":"Adenocarcinoma and Barrett\u2019s esophagus. An overrated risk?","volume":"87","author":"Spechler","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM198510033131404","article-title":"The incidence of adenocarcinoma in columnar-lined (Barrett\u2019s) esophagus","volume":"313","author":"Cameron","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.dld.2005.04.013","article-title":"Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett\u2019s oesophagus","volume":"37","author":"Gerson","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1572-0241.1998.211_a.x","article-title":"Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett\u2019s esophagus","volume":"93","author":"Ouatu-Lascar","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1572-0241.2004.30228.x","article-title":"Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett\u2019s esophagus","volume":"99","author":"El-Serag","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2004.tb05991.x","article-title":"Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett\u2019s oesophagus","volume":"180","author":"Hillman","year":"2004","journal-title":"Med J Aust"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1172\/JCI119018","article-title":"Dynamic effects of acid on Barrett\u2019s esophagus. An ex vivo proliferation and differentiation model","volume":"98","author":"Fitzgerald","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1053\/gast.2002.30993","article-title":"Acid exposure activates the mitogen-activated protein kinase pathways in Barrett\u2019s esophagus","volume":"122","author":"Souza","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1572-0241.2004.04054.x","article-title":"In vitro acid exposure has a differential effect on apoptotic and proliferative pathways in a Barrett\u2019s adenocarcinoma cell line","volume":"99","author":"Morgan","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/gut.45.2.172","article-title":"Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification","volume":"45","author":"Lundell","year":"1999","journal-title":"Gut"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1572-0241.1998.00362.x","article-title":"Practice guidelines on the diagnosis, surveillance, and therapy of Barrett\u2019s esophagus. The Practice Parameters Committee of the American College of Gastroenterology","volume":"93","author":"Sampliner","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/gast.1996.1101982","article-title":"Clinical esophageal pH recording: a technical review for practice guideline development","volume":"110","author":"Kahrilas","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/0016-5085(94)90815-X","article-title":"The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data","volume":"107","author":"Weusten","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.gastro.2004.04.010","article-title":"A critical review of the diagnosis and management of Barrett\u2019s esophagus: the AGA Chicago Workshop","volume":"127","author":"Sharma","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB20|cit20","first-page":"582","article-title":"Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett\u2019s esophagus","volume":"92","author":"Sharma","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0016-5107(96)70055-X","article-title":"Partial regression of Barrett\u2019s esophagus by long-term therapy with high-dose omeprazole","volume":"44","author":"Malesci","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2036.2004.02127.x","article-title":"Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett\u2019s oesophagus treated with proton pump inhibitors","volume":"20","author":"Gerson","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB23|cit23","first-page":"G47","article-title":"Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett\u2019s esophagus","volume":"275","author":"Fitzgerald","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB24|cit24","first-page":"990","article-title":"Cyclooxygenase-2 expression in the Barrett\u2019s metaplasia-dysplasia-adenocarcinoma sequence","volume":"96","author":"Morris","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0016-5085(93)90017-7","article-title":"Barrett\u2019s esophagus: cell cycle abnormalities in advancing stages of neoplastic progression","volume":"105","author":"Reid","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1590\/S1807-59322005000200005","article-title":"Origin of adenocarcinoma in Barrett\u2019s esophagus: p53 and Ki67 expression and histopathologic background","volume":"60","author":"Szachnowicz","year":"2005","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB27|cit27","first-page":"962","article-title":"Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett\u2019s esophagus","volume":"47","author":"Halm","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s10350-004-6120-5","article-title":"Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer","volume":"45","author":"Yamauchi","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/bjs.1800801244","article-title":"Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis","volume":"80","author":"Nugent","year":"1993","journal-title":"Br J Surg"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000028306","article-title":"Relative efficacies of gastric proton pump inhibitors: their clinical and pharmacological basis","volume":"59","author":"Kromer","year":"1999","journal-title":"Pharmacology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/gast.1999.0029900327","article-title":"Differentiation and proliferation in Barrett\u2019s esophagus and the effects of acid suppression","volume":"117","author":"Ouatu-Lascar","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/17425250903124363","article-title":"The pharmacology of esomeprazole and its role in gastric acid related diseases","volume":"5","author":"Saccar","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/17474124.3.1.15","article-title":"Esomeprazole: a proton pump inhibitor","volume":"3","author":"Vachhani","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","article-title":"Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study","volume":"98","author":"Miner","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00044011-200828060-00001","article-title":"Effect of increasing esomeprazole and pantoprazole doses on acid control in patients with symptoms of gastro-oesophageal reflux disease: a randomized, dose-response study","volume":"28","author":"Wilder-Smith","year":"2008","journal-title":"Clin Drug Investig"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0002-9610(98)00258-X","article-title":"Reflux-induced apoptosis of the esophageal mucosa is inhibited in Barrett\u2019s epithelium","volume":"176","author":"Wetscher","year":"1998","journal-title":"Am J Surg"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1365-2168.2002.02229.x","article-title":"Apoptosis in Barrett\u2019s oesophagus following antireflux surgery","volume":"89","author":"Chen","year":"2002","journal-title":"Br J Surg"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1038\/sj.onc.1204947","article-title":"Proton pump inhibitors reduce cell cycle abnormalities in Barrett\u2019s esophagus","volume":"20","author":"Umansky","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2165\/00003495-200262100-00006","article-title":"Esomeprazole: a review of its use in the management of acid-related disorders","volume":"62","author":"Scott","year":"2002","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1592\/phco.23.4.460.32128","article-title":"Pharmacogenetics of the proton pump inhibitors: a systematic review","volume":"23","author":"Chong","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S1590-8658(01)80115-8","article-title":"Clinical pharmacology and safety profile of esomeprazole, the first enantiomerically pure proton pump inhibitor","volume":"33","author":"Tonini","year":"2001","journal-title":"Dig Liver Dis"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0009-9236(97)90081-3","article-title":"Metabolic disposition of pantoprazole, a proton pump inhibitor, in relation to S-mephenytoin 4\u2019-hydroxylation phenotype and genotype","volume":"62","author":"Tanaka","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1365-2036.2011.04616.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1572-0241.1998.00331.x","article-title":"Is Barrett\u2019s esophagus characterized by more pronounced acid reflux than severe esophagitis?","volume":"93","author":"Coenraad","year":"1998","journal-title":"Am J Gastroenterol"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04616.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04616.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:56:45Z","timestamp":1625435805000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04616.x"}},"subtitle":["Randomised clinical trial: double-dose PPI in patients with Barrett\u2019s oesophagus"],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04616.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}